Selective modification of HK peptides enhances siRNA silencing of tumor targets in vivo
Authors:
Open Access
- 5 August 2011
- journal article
- research article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 18 (10) , 707-716
Abstract
Our research has focused on systemic delivery of small interference RNA (siRNA) by branched peptides composed of histidine and lysine. After studying several histidine-lysine (HK) peptides, one four-branched peptide, H3K(+H)4b, with a predominant repeating pattern of -HHHK-, was found to be an effective carrier of siRNA. Although the unmodified H3K(+H)4b carrier of siRNA targeting an oncogene was previously shown to have promise in a tumor-bearing mouse model, we sought to develop a more effective HK carrier of siRNA in this study. Our primary goal was to determine whether different ligand (cyclic RGD)-pegylation patterns on the H3K(+H)4b peptide affect siRNA delivery in vitro and in vivo. We compared the unmodified H3K(+H)4b with two modified H3K(+H)4b peptides for their ability to deliver siRNA in a tumor-bearing mouse model; one modified HK peptide, (RGD-PEG)4-H3K(+H)4b, had four cyclic RGD-polyethylene glycol (cRGD-PEG) conjugates per molecule, whereas the other peptide, (RGD-PEG)-H3K(+H)4b, had one cRGD-PEG per molecule. Although the modified HK peptides by themselves did not form stable nanoplexes with siRNA, combination of a highly charged unmodified HK peptide, H2K4b, with either of the modified HK peptides did form stable siRNA nanoparticles. For in vitro experiments with MDA-MB-435 cells that expressed luciferase (Luc), the H3K(+H)4b siRNA nanoplexes targeting Luc decreased its activity by 90% compared with negligible downregulation by the modified H3K(+H)4b nanoplexes (P4-H3K(+H)4b nanoplexes decreased by 18, 35 and 75%, respectively. Thus, the siRNA nanoplex incorporating the highly modified peptide, (RGD-PEG)4-H3K(+H)4b, was the most effective at silencing its target in vivo (P<0.01). These studies demonstrate that selectively modified HK polymers are promising candidates for targeting oncogenes with siRNA.Keywords
This publication has 46 references indexed in Scilit:
- Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumorsNature Biotechnology, 2009
- Template Assembled Cyclopeptides as Multimeric System for Integrin Targeting and EndocytosisJournal of the American Chemical Society, 2004
- Rational siRNA design for RNA interferenceNature Biotechnology, 2004
- Endothelial cells internalize and degrade RGD-modified proteins developed for tumor vasculature targetingJournal of Controlled Release, 2002
- Tumor Regression by Targeted Gene Delivery to the NeovasculatureScience, 2002
- Optimal transfection with the HK polymer depends on its degree of branching and the pH of endocytic vesiclesNucleic Acids Research, 2002
- Argonaute2, a Link Between Genetic and Biochemical Analyses of RNAiScience, 2001
- Branched co-polymers of histidine and lysine are efficient carriers of plasmidsNucleic Acids Research, 2001
- Integrin activation controls metastasis in human breast cancerProceedings of the National Academy of Sciences, 2001
- An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cellsNature, 2000